84
Participants
Start Date
January 9, 2023
Primary Completion Date
August 30, 2024
Study Completion Date
December 30, 2024
Probiotic Group
The 84 participants will participate in a randomized, double-blind, placebo-controlled trial in two arms. The probiotic group will consist of 42 patients. These patients will be recruited from the USP Bipolar Disorder Program. This program has an outpatient clinic that offers free medical care to a population of different ethnic groups, with the majority of subjects coming from the middle and lower social classes.
Placebo Group
The 84 participants will participate in a randomized, double-blind, placebo-controlled trial in two arms. The placebo group will consist of 42 patients. These patients will be recruited from the USP Bipolar Disorder Program. This program has an outpatient clinic that offers free medical care to a population of different ethnic groups, with the majority of subjects coming from the middle and lower social classes.
RECRUITING
University of Sao Paulo, São Paulo
Collaborators (1)
Baszucki Brain Research Fund
OTHER
Milken Institute
OTHER
University of Sao Paulo
OTHER